Marino Garcia

Insider Reports History

Entity
Individual
Location
C/O Synergy Pharmaceuticals Inc., 420 Lexington Avenue, Suite 2012, New York, New York
Signature
/s/ Adam Veness, as attorney-in-fact for Marino Garcia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marino Garcia:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dianthus Therapeutics, Inc. /DE/ CEO AND PRESIDENT, Director Stock Option (Right to Buy) 243K May 23, 2024 Direct

Insider Reports Filed by Marino Garcia

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNTH Dianthus Therapeutics, Inc. /DE/ May 23, 2024 1 $0 4 May 28, 2024 CEO AND PRESIDENT, Director
DNTH Dianthus Therapeutics, Inc. /DE/ Jan 24, 2024 1 $0 4 Jan 26, 2024 CEO AND PRESIDENT, Director
MGTA Dianthus Therapeutics, Inc. /DE/ Sep 11, 2023 0 $0 3 Sep 13, 2023 CEO and President, Director